Novo Nordisk, the Danish maker of the injectable diabetes drug Ozempic and its sister weight-loss medicine Wegovy, is planning to slash prices amid both…
Novo Nordisk has been slowly increasing production capacity of its highly coveted weight loss drugs. As a result, thousands of people have began treatment per week.